Praxis Dr. Noel
- Address
- Roermonder Straße 326, 52072 Aachen, Germany
Praxis Dr. Noel - Women's Health Research Center
Praxis Dr. Noel is a specialized clinical research facility dedicated to advancing therapeutic solutions for women's health conditions. The center focuses on investigating innovative treatment approaches for common gynecological disorders that significantly impact women's quality of life, with particular expertise in reproductive health disorders and vaginal infections.
- Live biotherapeutic products for acute vaginal infections including bacterial vaginosis and vulvovaginal candidiasis
- Herbal medicine interventions for primary dysmenorrhea and menstrual-related disorders
- First-line monotherapy alternatives for gynecological conditions
The research center conducts rigorous randomized, double-blind, placebo-controlled trials to evaluate both novel biological therapeutics and plant-based medicines. Their clinical trial portfolio demonstrates a commitment to evidence-based approaches in treating conditions such as bacterial vaginosis, vulvovaginal candidiasis, and primary dysmenorrhea, with emphasis on dose-response relationships and patient safety profiles.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Praxis Dr. Noel
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy of Vitex agnus-castus BNO 1095 in the Management of Primary Dysmenorrhea in Women: A Randomized, Double-Blind, Placebo-Controlled Trial | Bionorica SE | Phase III | Not Recruiting | Nov 2023 | Jul 2025 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dry Extract From Chaste Tree Fruits (7-11:1), Extraction Solvent: Ethanol 70% (V/V) | 1 | Unknown | 2023-11-28 | 2023-11-28 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.